Results 211 to 220 of about 187,564 (336)

Exophytic Hepatic Hemangioma Mimicking a Right Adrenal Gland Mass: A Diagnostic Challenge. [PDF]

Cureus
Arumugam A, Abualruz AR, Ghleilib I, Pillenahalli Maheshwarappa R.   +3 more
europepmc   +1 more source

78 Primary Adrenal Gland Epithelioid Sarcoma [PDF]

, 2018
Xiao Huang, Haijun Zhou
openalex   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Emergency embolisation of acute adrenal gland haemorrhages due to underlying neoplasms - multicentre experience and literature overview. [PDF]

Pol J Radiol
Szmygin M, Szmygin H, Giurazza F, Pyra K, Lenart-Lipińska M.   +4 more
europepmc   +1 more source

Non‐canonical PKG1 regulation in cardiovascular health and disease

British Journal of Pharmacology, EarlyView.
It is well established that the cyclic GMP‐dependent protein kinase I (PKG1) is canonically activated by cyclic guanosine monophosphate (cGMP), enabling its regulation of vascular tone, cardiac function and smooth muscle homeostasis. However, diverse non‐canonical stimuli of PKG1 have also been identified.
Jie Su, Joseph Robert Burgoyne
wiley   +1 more source

The Transcriptome Trajectory Reveals Sex- and Age-Dependent Changes in the Mouse Adrenal Gland. [PDF]

Aging Cell
Wang H, Maggard B, Zheng HS, Kang Y, Huang CJ.   +4 more
europepmc   +1 more source

Editorial The adrenal gland in acute illness

, 2006
Fraser Pirie
openalex   +1 more source

An intracellular recombinant single‐chain variable antibody fragment as a new class of phosphodiesterase type 5 inhibitors

British Journal of Pharmacology, EarlyView.
Background and Purpose Cyclic guanosine monophosphate (cGMP) is a ubiquitous second messenger involved in human (patho‐)physiology. Phosphodiesterase 5 (PDE5) is a major cGMP hydrolyzing enzyme in many cell types including vascular smooth muscle cells (VSMCs). Several highly selective PDE5 inhibitors are in clinical use. However, there are currently no
Kürsat Kirkgöz, Sophie Sprenger, Olga Schweigert, Sanika Mohagaonkar, Matti Walsdorff, Tanja Zeller, Filip Berisha, Viacheslav O. Nikolaev, Sergei D. Rybalkin   +8 more
wiley   +1 more source

Histomorphological and ultrastructural determination of the adrenal gland in swan geese (<i>Anser cygnoides</i>). [PDF]

Open Vet J
Alkhazraji KIA, Almaliki SH, Naser RA, Al-Ezzy AIA, Zghair FS.   +4 more
europepmc   +1 more source

Thyroid function tests in endemic goitre [PDF]

, 1967
Alberts, H., Beckebans, J., Richter, J., Schwarz, K., Scriba, Peter Christian   +4 more
core   +1 more source